Statement prepared by the Health Food Manufacturers’ Association (HFMA) in response to Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function” (The AREDS2 Randomized Clinical Trial) by Emily Y. Chew,
this study used a formulation which was high in EPA but had a relatively low dose of DHA (350mg), whereas the scientific consensus is that DHA is the key fatty acid for prevention of cognitive decline. Previous studies that have demonstrated a benefit in this area such as the MIDAS study have almost exclusively supplemented high doses of DHA
“The general public and healthcare professionals are advised to consider the new findings alongside other robust research in this area before drawing any conclusions.” Said Graham Keen, Executive Director of the HFMA.
“For example, a large-scale study published in the Neurology journal showed that those who consumed the most omega-3 had the highest scores in tests for memory, speed and complicated information processing and overall cognition[1].”
“The authors of this recent JAMA study acknowledged that the duration of supplementation (5 years) may have been insufficient to observe an effect on cognitive decline, which may occur over decades. The authors also noted the possibility that supplementation started too late in the aging process (mean age at baseline was 72.7 years) to have a measurable effect on cognition. Co-author of the study, Dr Lenore Launer, from the US National Institute on Ageing, also said: “It may be, for example, that the timing of nutrients, or consuming them in a certain dietary pattern, has an impact. More research would be needed to see if dietary patterns or taking the supplements earlier in the development of diseases like Alzheimer’s would make a difference.”
The fact is that omega-3 ingredients are one of the most researched and scientifically proven functional ingredients. In 2013, Omega-3 supplements also received major recognition for their benefits by having three health claims approved by EU law and supported by the European Food Safety Authority (EFSA). Due to the rigor of this European regulation, not only does this ruling provide further evidence towards the benefits of Omega-3, but it also provides strong testament to its safety.
“Supplementation is essential for some groups1 and for thousands of individuals across the UK, these products also help to safeguard nutritional intakes and achieve optimum micronutrient levels.”
Issued on behalf of: HFMA Issued by: Pegasus Press enquiries: Matt Steele or Vicky Flannigan on 01273 712 000 or msteele@thisispegasus.co.uk or vflannigan@thisispegasus.co.uk The HFMA
[1] Kalmijn S, van Boxtel MP, Ocké M, Verschuren WM, Kromhout D, Launer LJ. Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology. 2004 Jan 27;62(2):275-80. PubMed PMID: 14745067.
1 The National Institute for Health and Care Excellence (NICE) recommends certain supplements for some groups of people who are at risk of deficiency, including: – Folic acid supplements during pregnancy – Vitamin D supplements should be taken by all pregnant and breastfeeding women, children aged six months to five years, people aged 65 and over, and those who are not exposed to much sun – All children aged six months to five years should take a supplement containing vitamins A, C and D
The Health Food Manufacturers’ Association (HFMA) is the voice of the UK’s natural health industry and represents more than 125 manufacturers and suppliers of natural health products.
Founded in 1965, the HFMA is a not-for-profit organisation which operates long-standing codes of practice to ensure that member companies adhere to high standards and offer good quality, safe products supported by responsible, lawful information.
For further information about the HFMA, visit www.hfma.co.uk.